Joint Facilities

In order to achieve decisive progress in immunology for affected patients, new biomedical techniques must be developed and used in connection with immunological analyses and biophysical disease models.

The prerequisite for patient-oriented, synergetic research is close scientific networking between different disciplines and free access to a wide range of state-of-the-art equipment in the immediate vicinity.

At the research sites Erlangen-Nürnberg, Regensburg and Würzburg, numerous (infra)structural measures have already been developed to enable innovative immunomedicine through the unique combination and structural interlinking of immune and personalised tumour therapy, biophysics as well as digital and transplantation medicine in close proximity to patient care.

Several new research buildings will be completed at the three sites by 2027. Their central goals: the development and application of new diagnostics and therapeutic methods for chronic inflammatory diseases and cancer.